Principal Investigator
Angela Branche
University of Rochester
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
BIOLOGICAL(2)
MIXED(1)
H7N9 pIIV
1 trial
phase_1
national-institute-of-allergy-and-infectious-diseases-niaidAS03 adjuvant
1 trial
phase_1
national-institute-of-allergy-and-infectious-diseases-niaidH7N9 pLAIV
1 trial
phase_1
national-institute-of-allergy-and-infectious-diseases-niaid3 unique interventions2 categories
Analytics
Trial Phases
Phase 11
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Influenza A Virus, H7N9 Subtype
PrincipalinvestigatorStart date: 2016-12-01
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
University of Rochester
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
3 similar investigators found
John Treanor, M.D.
University of Rochester
3 trials
Shared therapeutic areas:
Influenza A Virus, H7N9 Subtype
Worked with same sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score30%
John Treanor, MD
University of Rochester
10 trials
Shared therapeutic areas:
Influenza A Virus, H7N9 Subtype
Worked with same sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score30%
Kawsar Talaat, MD
Johns Hopkins Bloomberg School of Public Health
9 trials
Shared therapeutic areas:
Influenza A Virus, H7N9 Subtype
Worked with same sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Influenza A Virus, H7N9 Subtype
All 1 trials loaded